This fast track antibody is not yet fully characterized. It is subject to these terms and conditions

製品の概要

  • 製品名Anti-PMS1 antibody
    PMS1 一次抗体 製品一覧
  • 製品の詳細
    Goat polyclonal to PMS1

    This product is a fast track antibody. It has been affinity purified and shows high titre values against the immunizing peptide by ELISA. Read the terms of use »

  • 種交差性

    交差が予測される動物種: Human
  • 免疫原

    Peptide with sequence RPFFHHLTYLPETT, from C Terminus of the protein sequence according to NP_000525.

製品の特性

  • 製品の状態Liquid
  • 保存方法Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
  • バッファーTris saline, 0.02% Na azide, pH7.3 with 0.5% BSA
  • Concentration information loading...
  • 精製度IgG fraction
  • 特記事項(精製)Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
  • ポリ/モノポリクローナル
  • アイソタイプIgG
  • 研究分野

アプリケーション

  • 追加情報ELISA: Peptide ELISA (antibody detection limit dilution 1:32,000).
    Western Blot: No signal obtained yet but low background observed in Human Brain and Kidney extracts at up to 2ug/ml.
  • ターゲット情報

    • 機能Probably involved in the repair of mismatches in DNA.
    • 関連疾患Defects in PMS1 are the cause of hereditary non-polyposis colorectal cancer type 3 (HNPCC3) [MIM:600258]. Mutations in more than one gene locus can be involved alone or in combination in the production of the HNPCC phenotype (also called Lynch syndrome). Most families with clinically recognized HNPCC have mutations in either MLH1 or MSH2 genes. HNPCC is an autosomal, dominantly inherited disease associated with marked increase in cancer susceptibility. It is characterized by a familial predisposition to early onset colorectal carcinoma (CRC) and extra-colonic cancers of the gastrointestinal, urological and female reproductive tracts. HNPCC is reported to be the most common form of inherited colorectal cancer in the Western world, and accounts for 15% of all colon cancers. Cancers in HNPCC originate within benign neoplastic polyps termed adenomas. Clinically, HNPCC is often divided into two subgroups. Type I: hereditary predisposition to colorectal cancer, a young age of onset, and carcinoma observed in the proximal colon. Type II: patients have an increased risk for cancers in certain tissues such as the uterus, ovary, breast, stomach, small intestine, skin, and larynx in addition to the colon. Diagnosis of classical HNPCC is based on the Amsterdam criteria: 3 or more relatives affected by colorectal cancer, one a first degree relative of the other two; 2 or more generation affected; 1 or more colorectal cancers presenting before 50 years of age; exclusion of hereditary polyposis syndromes. The term 'suspected HNPCC' or 'incomplete HNPCC' can be used to describe families who do not or only partially fulfill the Amsterdam criteria, but in whom a genetic basis for colon cancer is strongly suspected.
    • 配列類似性Belongs to the DNA mismatch repair mutL/hexB family.
      Contains 1 HMG box DNA-binding domain.
    • 細胞内局在Nucleus.
    • Information by UniProt
    • 参照データベース
    • 別名
      • DNA mismatch repair protein PMS1 antibody
      • FLJ98259 antibody
      • HNPCC3 antibody
      • hPMS1 antibody
      • Human homolog of yeast mutL antibody
      • Mismatch repair gene PMSL1 antibody
      • pms1 antibody
      • PMS1 postmeiotic segregation increased 1 (S. cerevisiae) antibody
      • PMS1 postmeiotic segregation increased 1 antibody
      • PMS1 protein homolog 1 antibody
      • PMS1_HUMAN antibody
      • PMSL1 antibody
      • Rhabdomyosarcoma antigen MU RMS 40.10B antibody
      • Rhabdomyosarcoma antigen MU RMS 40.10E antibody
      see all

    Anti-PMS1 antibody (ab3818) 使用論文

    ab3818 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab3818.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"